← FDA Drug Approvals (Drugs@FDA)

TACROLIMUS

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHENGDU · Approved 2024-01-25

Drug application

FDA Application #

ANDA215012

Application type

Abbreviated New Drug Application (Generic)

Brand name

TACROLIMUS

Generic name

TACROLIMUS

Active ingredients

TACROLIMUS

Dosage form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

CHENGDU

Manufacturer

Amneal Pharmaceuticals NY LLC

First approval

2024-01-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown